Send me a link:

*Text messaging rates may apply.

 Dow Up0.17% Nasdaq Up0.44%

Opexa Therapeutics, Inc. (OPXA)

-NasdaqCM
1.58 Up 0.01(0.64%) Jul 11, 3:56PM EDT
ProfileGet Profile for:
Opexa Therapeutics, Inc.
2635 Technology Forest Boulevard
The Woodlands, TX 77381
United States - Map
Phone: 281-272-9331
Fax: 281-872-8585
Website: http://www.opexatherapeutics.com

Details 
Index Membership:N/A
Sector:Healthcare
Industry:Biotechnology
Full Time Employees:38

Business Summary 

Opexa Therapeutics, Inc., a biopharmaceutical company, develops personalized immunotherapy to treat multiple sclerosis (MS) based on its proprietary T-cell technology. Its product candidate is Tcelna, a novel T-cell immunotherapy, which is in Phase IIb clinical development for the treatment of patients with secondary progressive MS. The company was formerly known as PharmaFrontiers Corp. and changed its name to Opexa Therapeutics, Inc. in June 2006. Opexa Therapeutics was founded in 2003 and is based in The Woodlands, Texas.

Key Statistics


Company Websites 
Home Page
Search Yahoo! for:
More on Opexa Therapeutics, Inc.

Key Executives 
 PayExercised
Mr. Neil K. Warma , 51
Chief Exec. Officer, Pres, Sec. and Director
490.00K0.00
Mr. Karthik Radhakrishnan CFA, 43
Chief Financial Officer and Principal Accounting Officer
231.00K0.00
Mrs. Donna R. Rill , 60
Chief Devel. Officer
284.00K0.00
Dr. Donald Healey Ph.D.,
VP of Scientific Devel.
N/AN/A
Mr. Kenny Frazier ,
VP of Clinical Devel. & Regulatory Affairs
N/AN/A
Amounts are as of Dec 31, 2013 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc.Exercised is the value of options exercised during the fiscal year.
Currency in USD.
View Insiders